Nasdaq
$1.19▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.9MShares out 1.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
48- 10.13Pre-market26.10.13 13:15filedEFFECTOther#●●●
HCW Biologics Inc.
The registration statement (File No. 333-299271) filed by HCW Biologics Inc. was declared effective by the SEC on October 9, 2026. This effectiveness allows the company to proceed with the issuance and offering of the securities described in the filing.…more
$1.19+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8Regular26.10.08 23:52DOther
HCW Biologics Inc.
HCW Biologics Inc. filed a Form D with the SEC on October 8, 2026, to report an exempt offering of securities. This filing indicates that the company has initiated a new capital raising activity through a securities offering.…more
$1.19+0.00%vs prev closeView filingShare - 10.2After-hours26.10.03 05:30S-1Offering
HCW Biologics Inc.
HCW Biologics has filed a registration statement for the resale of up to 1,807,228 shares of common stock, consisting of shares issuable upon the exercise of pre-funded warrants and future common stock warrants subject to stockholder approval. The company will not receive proceeds from this resale, which relates to a private placement transaction finalized in September 2026. The company previously effected a 1-for-6 reverse stock split on June 30, 2026.…more
$1.19+0.00%vs prev closeView filingShare
47 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.9Pre-market26.10.09 22:00#●●●#●●●
HCW Biologics Advances IND Filing Plans for Solid Tumor Candidate
HCW Biologics has received regulatory guidance from the FDA and remains on track to file an IND application for its solid tumor candidate, HCW11-018b, in the first half of 2027. This update reflects progress in the regulatory process rather than clinical efficacy or commercial results.…more
$1.19+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.2After-hours26.10.03 05:33
●●●●●●●● ●●●●● ●●●●●●
HCW Biologics has filed a prospectus for the resale of up to 1,807,228 shares underlying warrants held by Armistice Capital. This filing indicates potential share dilution as the underlying warrants are exercised and shares become available for sale.…more
$1.19+0.00%vs prev closeShareBenzinga - 9.24Pre-market26.09.24 21:25
●●●●●●●● ●●●●● ●●●●●●
HCW Biologics has announced a $1.5 million private placement with an existing stockholder. The proceeds will be used to fund clinical trials and advance the company's drug development pipeline.…more
$1.19+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report